Morgan Stanley Maintains Equal-Weight on Steris, Lowers Price Target to $215
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on Steris (NYSE:STE) but reduced the price target from $225 to $215.

December 04, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Steris's stock may experience limited short-term price movement as Morgan Stanley maintains an Equal-Weight rating but lowers the price target from $225 to $215.
The adjustment in price target by a major analyst like Morgan Stanley could influence investor sentiment, but since the rating remains unchanged at Equal-Weight, the impact may be moderate. The reduction in price target suggests a slightly less optimistic outlook on the company's valuation, which could lead to some negative sentiment among investors. However, the lack of a rating downgrade means that the overall stance on the company's prospects remains steady, which might mitigate any negative impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100